SHENGCHANG SU: Open Payments
NPI 1831964782 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,592 in 14 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $925 · 2025 $1,592
Food & beverage: $1,592
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $294 |
| Sequel Med Tech, LLC | 2 | $243 |
| SANOFI-AVENTIS U.S. LLC | 2 | $221 |
| BETA BIONICS, INC. | 1 | $146 |
| Medtronic, Inc. | 1 | $133 |
| Insulet Corporation | 1 | $132 |
| Tandem Diabetes Care, Inc. | 1 | $130 |
| Lilly USA, LLC | 1 | $120 |
| Xeris Pharmaceuticals, Inc. | 1 | $119 |
| CeQur Corporation | 1 | $54 |
Products named: TWIIST, TZIELD, Wegovy, iLet Bionic Pancreas, MINIMED 780G, OMNIPOD, t:slim X2 Insulin Pump with Control-IQ, ZEPBOUND.
Industry payments across OH — which companies pay providers there.
